Jeff Haxer
Associé, Chicago
Merger & Acquisition (M&A) expert in our Healthcare practice, including pharma, medical devices and insurance
À propos de Jeff
Expertise
Highlights
- Expert in our M&A, Supply Chain Management and Healthcare practices
- Leader of dozens of corporate and PE due diligence assessments, multiple post-merger integration assignments and several complex separations/carve-outs
Jeff Haxer is a partner and expert in our Mergers & Acquisitions, Supply Chain Management and Healthcare practices, based in Chicago.
He advises clients across a range of industries, including pharmaceuticals (small and large molecule), medical devices, automotive, insurance, distribution (cold chain and non-cold chain), packaging (rigid and flexible) and agriculture.
Jeff has led more than 35 corporate and PE due diligence assessments, multiple post-merger integration assignments and several complex separations and carve-outs. His supply chain performance improvement experience includes in-plant complexity reduction work, installation of S&OP and forecasting/inventory planning processes, inventory optimization and network optimization.
Prior to joining the firm, Jeff worked in other consulting roles, helping clients improve operations across the automotive and pharmaceutical distribution industries.
Jeff earned an MBA from the MIT Sloan School of Management and a BBA, with honors, from the University of Michigan.
Recent Insights
- “Corporate M&A: For Public Healthcare Companies, It’s All about Revenue Growth,” Rapport, 8 mars 2020
- “Corporate M&A: Healthcare Acquisitions Feed Revenue Growth,” Rapport, 17 avril 2019
- “Global Healthcare Corporate M&A 2018,” Etude, 13 avril 2018
- “Jeff Haxer: Commercial Due Diligence in Healthcare,” Video, 17 juillet 2017
- “Jeff Haxer: How Biopharma Can Reward Shareholders,” Video, 15 juin 2017